Low use of neuroleptic drugs in the treatment of psychotic major depression
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The adequacy of pharmacologic treatment received by patients with psychotic major depression was evaluated. METHOD: The authors systematically assessed the pharmacotherapy received by 187 depressed patients before initiation of ECT and compared the medication trials of those with psychotic (N = 53) and nonpsychotic (N = 134) depression. RESULTS: Despite a median of four medication trials and median index episode duration of 20 weeks, only two (4%) of the patients with psychotic depression received at least one adequate pharmacotherapy trial. In contrast, 70 (52%) of the patients with nonpsychotic depression received at least one adequate trial. Twenty-five (47%) of the patients with psychotic depression received either no neuroleptic treatment (N = 11) or treatment for less than 3 weeks (N = 14). Only eight (15%) received a daily neuroleptic dose higher than 200 mg of chlorpromazine equivalents. CONCLUSIONS: These findings suggest that many patients with psychotic major depression referred for ECT receive inadequate pharmacotherapy because of either the absence or the inadequate use of neuroleptic medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice guideline for major depressive disorder in adults. American Psychiatric Association
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.1 · Cited by 226
Cited by
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686
“Nortriptyline-lithium was also selected since few ECT remitters would have received this treatment during the episode.(34,42)”
BackgroundSelf-citationECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE
Petrides, G., Fink, M., Husain, M. M., Knapp, R. G., Rush, A. J., Mueller, M., Rummans, T. A., O'Connor, K. M., Rasmussen, K. G., Bernstein, H. J., et al. (2001) · The Journal of ECT · doi:10.1097/00124509-200112000-00003 · Cited by 494
The Effects of Electroconvulsive Therapy on Memory of Autobiographical and Public Events
Lisanby, S. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.6.581 · Cited by 360
Convulsive therapy: a review of the first 55 years
Fink, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00367-0 · Cited by 265
Acute Efficacy of ECT in the Treatment of Major Depression in the Old-Old
Tew, J. D., Mulsant, B. H., Haskett, R. F., Prudic, J., Thase, M. E., Crowe, R. R., Dolata, D., Begley, A. E., Reynolds, C. F., & Sackeim, H. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1865 · Cited by 231
Self-citationOquendo, M. A., Malone, K. M., Ellis, S. P., Sackeim, H. A., & Mann, J. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.190 · Cited by 127
Self-citationSackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
What was learned: studies by the consortium for research in ECT(CORE) 1997–2011
Fink, M. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12251 · Cited by 97
(2003) · PubMed · Cited by 69
Acupuncture for the Treatment of Major Depressive Disorder: A Randomized Controlled Trial
Andreescu, C., Glick, R. M., Emeremni, C. A., Houck, P. R., & Mulsant, B. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06105 · Cited by 55
Self-citationA unilateral, prolonged, nonconvulsive seizure in a patient treated with bilateral ECT
Parker, V., Nobler, M. S., Pedley, T. A., & Sackeim, H. A. (2001) · The Journal of ECT · doi:10.1097/00124509-200106000-00010 · Cited by 13
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-04-01
- Volume
- 154
- Issue
- 4
- Pages
- 559-561
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W61639953
- Cited by
- 73
- References
- 1
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.